Ignite Creation Date:
2025-12-26 @ 1:16 PM
Ignite Modification Date:
2025-12-31 @ 8:32 PM
Study NCT ID:
NCT05239806
Status:
UNKNOWN
Last Update Posted:
2022-04-11
First Post:
2022-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine
Sponsor:
Sinocelltech Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-14
First Submit QC Date:
None
Study First Post Date:
2022-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-01
Last Update Post Date:
2022-04-11
Last Update Post Date Type:
ACTUAL